157 related articles for article (PubMed ID: 16623302)
1. Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience.
Manenti G; Squillaci E; Carlani M; Mancino S; Di Roma M; Simonetti G
Radiol Med; 2006 Feb; 111(1):22-32. PubMed ID: 16623302
[TBL] [Abstract][Full Text] [Related]
2. Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy.
Yuen JS; Thng CH; Tan PH; Khin LW; Phee SJ; Xiao D; Lau WK; Ng WS; Cheng CW
J Urol; 2004 Apr; 171(4):1482-6. PubMed ID: 15017203
[TBL] [Abstract][Full Text] [Related]
3. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
4. Role of magnetic resonance spectroscopic imaging ([¹H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA).
Panebianco V; Sciarra A; Ciccariello M; Lisi D; Bernardo S; Cattarino S; Gentile V; Passariello R
Radiol Med; 2010 Dec; 115(8):1314-29. PubMed ID: 20852963
[TBL] [Abstract][Full Text] [Related]
5. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.
Amsellem-Ouazana D; Younes P; Conquy S; Peyromaure M; Flam T; Debré B; Zerbib M
Eur Urol; 2005 May; 47(5):582-6. PubMed ID: 15826747
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negative TRUS-guided biopsy results.
Bhatia C; Phongkitkarun S; Booranapitaksonti D; Kochakarn W; Chaleumsanyakorn P
J Med Assoc Thai; 2007 Jul; 90(7):1391-9. PubMed ID: 17710982
[TBL] [Abstract][Full Text] [Related]
7. MR spectroscopy of prostate cancer. Initial clinical experience.
Squillaci E; Manenti G; Mancino S; Carlani M; Di Roma M; Colangelo V; Simonetti G
J Exp Clin Cancer Res; 2005 Dec; 24(4):523-30. PubMed ID: 16471314
[TBL] [Abstract][Full Text] [Related]
8. PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations.
Panebianco V; Sciarra A; De Berardinis E; Busetto GM; Lisi D; Buonocore V; Gentile V; Di Silverio F; Passariello R
Anticancer Res; 2011 Apr; 31(4):1399-405. PubMed ID: 21508392
[TBL] [Abstract][Full Text] [Related]
9. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
10. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
11. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
[TBL] [Abstract][Full Text] [Related]
12. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
13. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
[TBL] [Abstract][Full Text] [Related]
14. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
Pucar D; Koutcher JA; Shah A; Dyke JP; Schwartz L; Thaler H; Kurhanewicz J; Scardino PT; Kelly WK; Hricak H; Zakian KL
Clin Prostate Cancer; 2004 Dec; 3(3):174-81. PubMed ID: 15636684
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection.
Gholizadeh N; Greer PB; Simpson J; Goodwin J; Fu C; Lau P; Siddique S; Heerschap A; Ramadan S
J Biomed Sci; 2021 Jul; 28(1):54. PubMed ID: 34281540
[TBL] [Abstract][Full Text] [Related]
16. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
18. Visually Estimated MRI Targeted Prostate Biopsy Could Improve the Detection of Significant Prostate Cancer in Patients with a PSA Level <10 ng/mL.
Lee DH; Nam JK; Park SW; Lee SS; Han JY; Lee SD; Lee JW; Chung MK
Yonsei Med J; 2016 May; 57(3):565-71. PubMed ID: 26996553
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy.
Testa C; Schiavina R; Lodi R; Salizzoni E; Tonon C; D'Errico A; Corti B; Morselli-Labate AM; Franceschelli A; Bertaccini A; Manferrarik F; Grigioni WF; Canini R; Martorana G; Barbiroli B
NMR Biomed; 2010 Nov; 23(9):1017-26. PubMed ID: 20882642
[TBL] [Abstract][Full Text] [Related]
20. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]